Dr. Mark Kirchhof discusses the late breaker presentations about HS and alopecia areata at the 2023 EADV Congress.

Dr. Mark Kirchoff reports lives from the 2023 EADV Congress in Berlin and gives insights into the pathogenesis of psoriasis.

Dupilumab successfully decreases IgE serum levels in AD patients regardless of dosing intervals, according to a recent study.

Researchers from QIMR Berghofer have uncovered new evidence that explores the trend that people with hair loss can be more susceptible to...

Risankizumab is effective at achieving skin clearance in moderate-to-severe plaque psoriasis in bio-naive patients.

In less than three weeks, on Oct. 21, the 9th annual Skin Spectrum Summit will be held at the Chestnut Conference Centre at the...

Researchers at Stanford University in California have identified the mechanisms in the skin that produce feelings of “tightness” after...

Race an ethnicity may not be associated with access to biologics for psoriasis patients in the United States.